Results 171 to 180 of about 3,549 (185)

Cost-efficiency and expanded access of prophylaxis for chemotherapy-induced (febrile) neutropenia: economic simulation analysis for the US of conversion from reference pegfilgrastim to biosimilar pegfilgrastim-cbqv

Journal of Medical Economics, 2020
Karen Macdonald, , Neda Alrawashdh
exaly  

Pharmacokinetics and Pharmacodynamics of Pegfilgrastim

Clinical Pharmacokinetics, 2012
Bing-Bing Yang, Yang Bing-Bing
exaly  

Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy

Supportive Care in Cancer, 2015
Yoshiaki Rai, Norikazu Masuda, Toshimi Takano   +2 more
exaly  

PF-06881894, a Proposed Biosimilar to Pegfilgrastim, Versus US-Licensed and EU-Approved Pegfilgrastim Reference Products (Neulasta®): Pharmacodynamics, Pharmacokinetics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy Volunteers

Advances in Therapy, 2020
Hsuan-Ming Yao
exaly  

Thoracic aortitis and aortic dissection following pegfilgrastim administration

European Journal of Cardio-thoracic Surgery, 2017
Yuki Sato, Shuichiro Kaji, Keisuke Tomii   +2 more
exaly  

Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry

Pediatric Blood and Cancer, 2009
Blandine Beaupain, Patrick Lutz, Pierre Bordigoni   +2 more
exaly  

Risk of chemotherapy-induced febrile neutropenia in cancer patients receiving pegfilgrastim prophylaxis: does timing of administration matter?

Supportive Care in Cancer, 2015
Derek Weycker, Rich Barron, Spiros Tzivelekis   +2 more
exaly  

Administration options for pegfilgrastim prophylaxis: patient and physician preferences from a cross-sectional survey

Supportive Care in Cancer, 2017
Brett Hauber, Brennan Mange, Mark A Price   +2 more
exaly  

Pegfilgrastim

Reactions Weekly, 2009
openaire   +1 more source

The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gynecologic malignancies

Gynecologic Oncology, 2009
Kellie S Matthews, T Michael Numnum, James E Kendrick   +2 more
exaly